Kelindi
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Early Detection Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression by Mobile Health App
Role: collaborator
Optimization of Mother-child Dyad Follow-up by a Multidomain Application: Real-world Cross Sectional Study
Role: collaborator
A Smartphone Application for Screening of Developmental Disorders in Children
Role: collaborator
Assessment of the Feasibility of Using a Smartphone Application for the Prevention and Screening of Burnout (BURNOUT ADVICE)
Role: collaborator
Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application
Role: collaborator
Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application
Role: collaborator
All 6 trials loaded